- EPIC-STI ADMINISTRATIVE CORE (WHEELER) The Administrative Core of the Epidemiology and Prevention Interdisciplinary Center for Sexually Transmitted Infections (EPIC-STI) will provide infrastructure and support activities to the Scientific Projects, Biostatistics and Bioinformatics Core and the Pilot Developmental Research Projects (DRPs) with oversight by the EPIC- STI Program Director. A central activity of the EPIC-STI will be to coordinate reviews of its DRPs through the NIAID STI- Cooperative Research Center's (CRC) Executive Committee. The Committee's recommendations will be implemented to support the scientific goals of the DRPs and align mentoring strategies to successfully bridge the gaps between early establishment of a new investigator's into STI careers. The EPIC-STI administration will also provide an infrastructure within the UNM Health Sciences Center (UNM-HSC) that enhances the interactions within the program and its collaborators and that supports and optimizes accomplishing the interdisciplinary aims of the Center. The goals and objectives of administrating the EPIC-STI are to: 1) Coordinate activities related to the development of the Center 2) Oversee the ongoing development and implementation of the DRP mentoring program and its associated scientific projects 3) Manage the fiscal resources of the Center and communication with the NIAID program 4) Maintain records, monitor and update compliance data related to Projects and Cores 5) Coordinate meetings among investigators at UNM, Harvard, Wolfson Institute of Preventive Medicine, and with external advisory board members, seminar speakers and the NIAID 6) Manage and schedule the travel and external reagent exchange and communications for the Center 7) Provide support for noncompetitive renewal reporting including production of an annual progress report 8) Manage requests for use of shared resources developed by the EPIC-STI 9) Interface with all center activities to update the contents of the EPIC-STI website

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program--Cooperative Agreements (U19)
Project #
1U19AI113187-01
Application #
8769911
Study Section
Special Emphasis Panel (ZAI1)
Project Start
Project End
Budget Start
2014-07-01
Budget End
2015-06-30
Support Year
1
Fiscal Year
2014
Total Cost
Indirect Cost
Name
University of New Mexico Health Sciences Center
Department
Type
DUNS #
City
Albuquerque
State
NM
Country
United States
Zip Code
87131
Lijek, Rebeccah S; Helble, Jennifer D; Olive, Andrew J et al. (2018) Pathology after Chlamydia trachomatis infection is driven by nonprotective immune cells that are distinct from protective populations. Proc Natl Acad Sci U S A 115:2216-2221
Frietze, Kathryn M; Lijek, Rebeccah; Chackerian, Bryce (2018) Applying lessons from human papillomavirus vaccines to the development of vaccines against Chlamydia trachomatis. Expert Rev Vaccines 17:959-966
Yokoyama, Christine C; Baldridge, Megan T; Leung, Daisy W et al. (2018) LysMD3 is a type II membrane protein without an in vivo role in the response to a range of pathogens. J Biol Chem 293:6022-6038
Castle, Philip E; Wheeler, Cosette M; Campos, Nicole G et al. (2018) Inefficiencies of over-screening and under-screening for cervical cancer prevention in the U.S. Prev Med 111:177-179
Arrossi, Silvina; Temin, Sarah; Garland, Suzanne et al. (2017) Primary Prevention of Cervical Cancer: American Society of Clinical Oncology Resource-Stratified Guideline. J Glob Oncol 3:611-634
Zhai, Lukai; Peabody, Julianne; Pang, Yuk-Ying Susana et al. (2017) A novel candidate HPV vaccine: MS2 phage VLP displaying a tandem HPV L2 peptide offers similar protection in mice to Gardasil-9. Antiviral Res 147:116-123
Ramírez-Peinado, Silvia; Ignashkova, Tatiana I; van Raam, Bram J et al. (2017) TRAPPC13 modulates autophagy and the response to Golgi stress. J Cell Sci 130:2251-2265
Cuzick, Jack; Myers, Orrin; Lee, Ji-Hyun et al. (2017) Outcomes in Women With Cytology Showing Atypical Squamous Cells of Undetermined Significance With vs Without Human Papillomavirus Testing. JAMA Oncol 3:1327-1334
Peabody, Julianne; Muttil, Pavan; Chackerian, Bryce et al. (2017) Characterization of a spray-dried candidate HPV L2-VLP vaccine stored for multiple years at room temperature. Papillomavirus Res 3:116-120
Laborde, Rady J; Sanchez-Ferras, Oraly; Luzardo, María C et al. (2017) Novel Adjuvant Based on the Pore-Forming Protein Sticholysin II Encapsulated into Liposomes Effectively Enhances the Antigen-Specific CTL-Mediated Immune Response. J Immunol 198:2772-2784

Showing the most recent 10 out of 18 publications